The FDA permitted manufacturers and businesses to make minor formulation changes to certain packaged food products and food labels to help offset disruptions or shortages of some ingredients during the COVID-19 pandemic. (Photo:  Daniel Acker/Bloomberg)

Last year, the U.S. Food and Drug Administration announced temporary policies aimed at providing manufacturers and businesses with limited flexibility on food labeling requirements and formulation adjustments of products for human consumption during the pandemic. These policies were implemented to provide regulatory flexibility and to minimize the impact of supply chain disruptions on product availability associated with the pandemic. But will these changes also create safety and health issues for consumers? Are these policies likely to continue in this new year?

Want to continue reading?
Become a Free PropertyCasualty360 Digital Reader

Your access to unlimited PropertyCasualty360 content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Breaking insurance news and analysis, on-site and via our newsletters and custom alerts
  • Weekly Insurance Speak podcast featuring exclusive interviews with industry leaders
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the employee benefits and financial advisory markets on our other ALM sites, BenefitsPRO and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

E&S/Specialty Lines
Commercial Lines
E&S/Specialty
Compliance